A genome-wide RNAi screen identifies multiple RSK-dependent regulators of cell migration

  1. Daniel A. Haber1,4,6
  1. 1Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Masachusetts 02129, USA;
  2. 2Broad Institute, Cambridge, Massachusetts 02142, USA;
  3. 3BioMEMS Resource Center, Center for Engineering in Medicine and Surgical Services, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA;
  4. 4Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts 02114, USA
    1. 5 These authors contributed equally to this work.

    Abstract

    To define the functional pathways regulating epithelial cell migration, we performed a genome-wide RNAi screen using 55,000 pooled lentiviral shRNAs targeting ∼11,000 genes, selecting for transduced cells with increased motility. A stringent validation protocol generated a set of 31 genes representing diverse pathways whose knockdown dramatically enhances cellular migration. Some of these pathways share features of epithelial-to-mesenchymal transition (EMT), and together they implicate key regulators of transcription, cellular signaling, and metabolism, as well as novel modulators of cellular trafficking, such as DLG5. In delineating downstream pathways mediating these migration phenotypes, we observed universal activation of ERKs and a profound dependence on their RSK effectors. Pharmacological inhibition of RSK dramatically suppresses epithelial cell migration induced by knockdown of all 31 genes, suggesting that convergence of diverse migratory pathways on this kinase may provide a therapeutic opportunity in disorders of cell migration, including cancer metastasis.

    Keywords

    Footnotes

    • Received January 20, 2010.
    • Accepted October 7, 2010.

    Freely available online through the Genes & Development Open Access option.

    | Table of Contents
    OPEN ACCESS ARTICLE

    Life Science Alliance